Search Results - "Meijer Laurent"

Refine Results
  1. 1

    Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview by Lindberg, Mattias F, Meijer, Laurent

    “…Dual-specificity tyrosine phosphorylation-regulated kinases (DYRK1A, 1B, 2-4) and cdc2-like kinases (CLK1-4) belong to the CMGC group of serine/threonine…”
    Get full text
    Journal Article
  2. 2

    Roscovitine and Other Purines as Kinase Inhibitors. From Starfish Oocytes to Clinical Trials by Meijer, Laurent, Raymond, Eric

    Published in Accounts of chemical research (17-06-2003)
    “…This article reviews the steps that have led us from very fundamental research on the cell division cycle, investigated with the starfish oocyte model, to the…”
    Get full text
    Journal Article
  3. 3

    An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs by Koslowski, Svenja, Latapy, Camille, Auvray, Pierrïck, Blondel, Marc, Meijer, Laurent

    “…Autosomal dominant polycystic kidney disease (ADPKD) is the most common inheritable cause of end stage renal disease and, as of today, only a single moderately…”
    Get full text
    Journal Article
  4. 4

    Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff’s bases by Sondhi, Sham M., Singh, Nirupma, Kumar, Ashok, Lozach, Olivier, Meijer, Laurent

    Published in Bioorganic & medicinal chemistry (01-06-2006)
    “…A series of N-(acridin-9-yl)-4-(benzo[ d]imidazol/oxazol-2-yl)benzamides ( 3a– f) has been synthesized by the condensation of 9-aminoacridine derivatives with…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The protein kinase CK1: Inhibition, activation, and possible allosteric modulation by Sunkari, Yashoda Krishna, Meijer, Laurent, Flajolet, Marc

    Published in Frontiers in molecular biosciences (24-08-2022)
    “…Protein kinases play a vital role in biology and deregulation of kinases is implicated in numerous diseases ranging from cancer to neurodegenerative diseases,…”
    Get full text
    Journal Article
  7. 7

    Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype by Walter, Anne, Chaikuad, Apirat, Helmer, Renate, Loaëc, Nadège, Preu, Lutz, Ott, Ingo, Knapp, Stefan, Meijer, Laurent, Kunick, Conrad

    Published in PloS one (03-05-2018)
    “…Cdc2-like kinases (CLKs) represent a family of serine-threonine kinases involved in the regulation of splicing by phosphorylation of SR-proteins and other…”
    Get full text
    Journal Article
  8. 8

    Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor by Brivanlou, Ali H, Sato, Noboru, Meijer, Laurent, Skaltsounis, Leandros, Greengard, Paul

    Published in Nature Medicine (01-01-2004)
    “…Human and mouse embryonic stem cells (HESCs and MESCs, respectively) self-renew indefinitely while maintaining the ability to generate all three germ-layer…”
    Get full text
    Journal Article Magazine Article
  9. 9

    (R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages by Shrestha, Chandra L., Zhang, Shuzhong, Wisniewski, Benjamin, Häfner, Stephanie, Elie, Jonathan, Meijer, Laurent, Kopp, Benjamin T.

    Published in Scientific reports (10-12-2020)
    “…Cystic fibrosis (CF) is characterized by chronic bacterial infections and heightened inflammation. Widespread ineffective antibiotic use has led to increased…”
    Get full text
    Journal Article
  10. 10

    CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome by Guen, Vincent J., Gamble, Carly, Flajolet, Marc, Unger, Sheila, Thollet, Aurélie, Ferandin, Yoan, Superti-Furga, Andrea, Cohen, Pascale A., Meijer, Laurent, Colas, Pierre

    “…Cyclin-dependent kinases (CDKs) regulate a variety of fundamental cellular processes. CDK10 stands out as one of the last orphan CDKs for which no activating…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design by Meine, Rosanna, Becker, Walter, Falke, Hannes, Preu, Lutz, Loaëc, Nadège, Meijer, Laurent, Kunick, Conrad

    Published in Molecules (Basel, Switzerland) (24-01-2018)
    “…Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a potential drug target because of its role in the development of Down syndrome and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives by Giraud, Francis, Alves, Georges, Debiton, Eric, Nauton, Lionel, Théry, Vincent, Durieu, Emilie, Ferandin, Yoan, Lozach, Olivier, Meijer, Laurent, Anizon, Fabrice, Pereira, Elisabeth, Moreau, Pascale

    Published in Journal of medicinal chemistry (14-07-2011)
    “…The synthesis of new meridianin derivatives is described. The indolic ring system was substituted at the C-4 to C-7 positions either by a bromine atom or by…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Indirubin Derivative 6BIO Suppresses Metastasis by BRAIG, Simone, KRESSIRER, Christine A, LIEBL, Johanna, BISCHOFF, Fabian, ZAHLER, Stefan, MEIJER, Laurent, VOLLMAR, Angelika M

    Published in Cancer research (Chicago, Ill.) (01-10-2013)
    “…While metastasis is the chief cause of cancer mortality, there nonetheless remains a lack of antimetastatic therapies that are clinically available. In this…”
    Get full text
    Journal Article
  19. 19

    Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models by Menn, Bénédicte, Bach, Stéphane, Blevins, Teri L, Campbell, Mark, Meijer, Laurent, Timsit, Serge

    Published in PloS one (12-08-2010)
    “…Although quite challenging, neuroprotective therapies in ischemic stroke remain an interesting strategy to counter mechanisms of ischemic injury and reduce…”
    Get full text
    Journal Article
  20. 20